Education & Training
- Residency: Washington University, Saint Louis, Missouri, 2020
- D.O.: Des Moines University, 2016
- B.S.: University of Dayton, 2010
Major Awards
- Dean’s Impact Award, 2026
Areas of Clinical Interest
perinatal behavioral health, substance use disorders
Research Interests
perinatal behavioral health, opioid use disorder
Recent Publications
-
Prescribing Trends in Glucagon-Like Peptide-1 Medications Among Pregnant and Postpartum Persons
Lessard, C., Cary, C., In, A., Steinle, J., Lin, B. Y., Kablinger, A. S., Grucza, R. A., Bello, J. K., Galati, B. M., Kimmel, M., Bruno, A. M., Kelly, J. C. & Xu, K. Y., Mar 2026, In: Obstetrics and gynecology. 147, 3, p. 290-292 3 p.
-
Discontinuation of treatment for alcohol use disorder during pregnancy and postpartum in the United States
Martin, C. E., Bello, J. K., Galati, B. M., Buss, J. L., Terplan, M., Jones, H. E., Mitchell, K. T., Martins, S. S., Grucza, R. A., Suarez, E. A. & Xu, K. Y., Sep 2025, In: Alcohol: Clinical and Experimental Research. 49, 9, p. 1972-1982 11 p.
-
Buprenorphine treatment during the extended postpartum period: a survey of patient experiences
Galati, B., Jacobsen, H., Kraus, M., Mills, M., Vaughn, B., Williams, S., Wenzinger, M., Rogers, C., Raghuraman, N. & Kelly, J., 2025, In: Journal of Maternal-Fetal and Neonatal Medicine. 38, 1, 2578576.
-
Buprenorphine Extended-Release Treatment for Opioid Use Disorder in the Postpartum Period
Galati, B. M., Wenzinger, M., Rogers, C. E., Cooke, E. & Kelly, J. C., Nov 1 2023, In: Obstetrics and gynecology. 142, 5, p. 1148-1152 5 p.
-
Transdermal buprenorphine for in-hospital transition from full agonist opioids to sublingual buprenorphine: a retrospective observational cohort study
Baumgartner, K., Salmo, E., Liss, D., Devgun, J., Mullins, M., Galati, B., Kelly, J. & Schwarz, E., 2022, In: Clinical Toxicology. 60, 6, p. 688-693 6 p.